MSB 0.00% $1.10 mesoblast limited

No Need to Stress! BUY like GOLD, HOLD like GOLD

  1. 628 Posts.
    lightbulb Created with Sketch. 93

    SP is highly likely to go up from where it is now as the Type A meeting gets closer.

    Price action 26OCt2020-31Oct2020 : SP like now tumbled, but SP ran UP again in Nov 2020
    Price Action: By NOV2020: SP started performing better 'cause Type A of that time was approaching.
    Just check Dec2020, SP went UP 'cause Type A of that time was approaching and over.

    There'll be a hype and vibe for the SP to be up closer to this time Type A
    .... Accumulation time to average down for the LTH may be going on. DYOR

    SP is highly likely to go up from where it is now as the Type A meeting gets closer.

    CEO must be regretting taking Karouse who and the FDA and the competitors have made couple of Slaps on his faces and then on his buttock, knee, and waist. He needs his own backpain killer.

    CEO must be working more carefully. Karouse may have misguided him.
    CEO should go for potential partnership with Big Pharma or look for new markets where products shown with safety and efficacy can/should be made available for the patients while works should be going on to meet FDA's criteria.

    In summary, SP is highly likely to go up from where it is now as the Type A meeting gets closer. GLTAH

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.